AzTrials
AzTrials

Bowel ObstructionOCCLUSNCT04848415

Diagnostic Performance of Point of Care Ultrasound to Identify Intestinal Obstruction

An observational study of Bowel Obstruction, run by Nantes University Hospital at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

As reported in previous studies, Point-of-Care Ultrasound (POCUS) has good performance for the diagnosis of bowel obstruction even when compared with CT. This inexpensive, radiation-free tool is available in a majority of ED. It is performed at the patient's bedside with immediate results. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Bowel Obstruction
What is being tested?
Point-of-Care Ultrasound
How many people
150 participants
Where
1 siteFrance
Study dates
1 May 2021to 1 Sep 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adult patients admitted to the ED for abdominal pain and suspicion of bowel obstruction

Who may be able to join

  • Adult patients
  • Abdominal pain
  • Suspected bowel obstruction

Who cannot join

  • Documented end-of-life precluding CT realization

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Nantes

    Nantes, 44093

Other trials in France

About this study

As reported in previous studies, Point-of-Care Ultrasound (POCUS) has good performance for the diagnosis of bowel obstruction even when compared with CT. This inexpensive, radiation-free tool is available in a majority of ED. It is performed at the patient's bedside with immediate results. The learning curve allows Emergency Physicians (EP) to perform this exam after a relative brief training period.

The investigators aim to investigate the ability of POCUS performed before CT to exclude the diagnosis of bowel obstruction in patients admitted for abdominal pain.

Read the detailed description

Bowel obstruction (BO) is frequently suspected in the Emergency Department (ED). Computed Tomography (CT) is commonly used to diagnose this disease. However, CT is not always available in real-time, requires technician times, is associated with increased cost and exposes patients to radiations.

The researchers will investigate the diagnosis performances of POCUS for the diagnosis of BO with comparison with CT which will be considered as the gold standard. The wain objective will be the ability to exclude the diagnosis of BO, the main criteria being the negative predictive value. The secondary objectives will be the diagnosis performances (sensitivity, specificity, positive predictive value), duration and difficulty of POCUS

Being tested
Point-of-Care Ultrasound
Keywords
Bowel obstruction, Computed tomography, Ultrasound
Medical subject headings
Intestinal Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Point-of-Care UltrasoundOther

    Patients admitted to the ED with abdominal pain and suspicion of bowel obstruction : realization of a Point-of-Care Ultrasound after clinical exam by the Emergency Physician in charge as a standard of care. Beside usual findings, the investigators will search for signs of bowel obstruction: dilated and incompressible small bowel loop, back-and-forth peristalsis sign. Determination of probability of small bowel obstruction. Realization of a computed tomography in search of small bowel obstruction.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Negative predictive value of POCUS

    Negative predictive value of POCUS for the diagnosis of bowel obstruction compared with computed tomography result

    Measured: Through ED stay, up to 24 hours

Secondary outcomes (3)
  1. Positive predictive value of POCUS for the diagnosis of bowel obstruction

    Positive predictive value

    Measured: Through ED stay, up to 24 hours

  2. Sensitivity of POCUS for the diagnosis of bowel obstruction

    sensitivity of POCUS, for the diagnosis of bowel obstruction compared with computed tomography result

    Measured: Through ED stay, up to 24 hours

  3. Specificity of POCUS for the diagnosis of bowel obstruction

    specificity of POCUS, for the diagnosis of bowel obstruction compared with computed tomography result

    Measured: Through ED stay, up to 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2021
  2. Study start1 May 2021
  3. Primary completion1 May 2022
  4. Study completion1 Sep 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04848415
Sponsor's protocol ID
OCCLUS
Acronym
OCCLUS
Status last verified
Jun 2026
First submitted
15 Feb 2021
Last updated
25 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Bowel Obstruction, run by Nantes University Hospital at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Negative predictive value of POCUS (time frame: Through ED stay, up to 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in